Codeine Market

Codeine Market - Size, Share,
Opportunity Analysis, 2018 – 2026
Outlook,
and
Codeine is a drug of class known as opioids, widely used in the treatment and management of
mild to moderate pain, severe pain, dry irritating cough, diarrhea, and cold and flu (when
combined with antihistamines and decongestants). Opioids interact with opioid receptors in the
brain and induce effects such as pain relief, relaxation, pleasure, and contentment. Codeine is
usually swallowed and comes in different forms, including tablets, capsules, and
solutions/syrups.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/2297
Codeine Market Drivers
Codeine is widely used in the treatment and management of pain and cough. High prevalence
of pain due to increasing ageing population in key regions such as North America, and AsiaPacific is expected to significantly increase demand for codeine formulation and drive global
codeine market growth over the forecast period.
For instance, according to the data published by National Health Interview Survey (NHIS) in
2016, it was estimated that around 20.4% (50.0 million) of the adults in the U.S. are suffering
from chronic pain and around 8.0% of adults in the U.S. (19.6 million) had high impact chronic
pain.
According to a study published by the National Centre for Biotechnology Information (NCBI) in
2015, around 19.6% of the individuals aged between 20 to 60 years were suffering from low
back pain worldwide.
Codeine Market Regional Analysis
North America codeine market is expected to hold a dominant position in the global codeine
market and to account for largest market share over the forecast period, owing to high presence
of key players in the region and approval and launch of novel products by them in the region.
For instance, in 2015, Tris Pharma, Inc. received U.S. Food and Drug Administration approval
and launched its Tuzistra XR (codeine polistirex and chlorpheniramine polistirex), extendedrelease oral suspension, CIII (DEA Schedule III) in the U.S. market. Tuzistra XR is indicated for
the treatment and relief of cough and symptoms associated with upper respiratory allergies or a
common cold in adults aged 18 years and older.
Report includes chapters which deeply display the following deliverable about industry :
• Codeine Market Research Objective and Assumption
• Codeine Market Purview - Report Description, Executive Summary, and Coherent Opportunity
Map (COM)
• Codeine Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Codeine Market, By Regions
• Codeine Market Competition by Manufacturers including Production, Share, Revenue, Average
Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Codeine Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Codeine Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers
of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Codeine Market Forecast including Production, Consumption, Import and Export Forecast by
Type, Applications and Region.
• Research Findings and Conclusion
Codeine Market Restraint
Stringent regulations in key regions for codeine formulation is expected to be a major factor
restraining growth of the codeine market in the near future. For instance, in February 2018,
The Therapeutic Goods Administration reclassified codeine as prescription only medicine in
Australia, which was previously available as over-the-counter medication. The fact behind this
reclassification was that regular use of medicines containing codeine may lead to its addiction.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/2297
Similarly, Health Canada also proposed to ban non-prescription codeine sales in 2017.
Reclassification of codeine to prescription drugs is expected to hinder its sales and adoption and
is expected to restrain the global codeine market growth over the forecast period
Codeine Market Key Players
Key players operating in global codeine market include: Nexgen Pharma, Inc., Teva
Pharmaceutical Industries Ltd., Wraser Pharmaceuticals LLC, Larken Laboratories, Inc.,
Aurobindo Pharma Limited, Sun Pharmaceutical Industries Limited, Tris Pharma Inc., and
Johnson & Johnson.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Codeine is a drug of class known as opioids, widely used in the treatment and management of mild to moderate pain, severe pain, dry irritating cough, diarrhea, and cold and flu

Download Report